---
title: "Don’t Let Life Sciences Innovation Become Another Coronavirus Casualty"
date: "2020-04-18"
issues: ["Biopharmaceutical Innovation"]
authors: ["Stephen Ezell", "Philip Stevens"]
content_type: "Op-Eds & Contributed Articles"
canonical_url: "https://itif.org/publications/2020/04/18/dont-let-life-sciences-innovation-become-another-coronavirus-casualty/"
---

# Don’t Let Life Sciences Innovation Become Another Coronavirus Casualty

With two-thirds of the world in lockdown and no clear way out of the novel coronavirus crisis, it’s increasingly obvious that biopharmaceutical innovation will play a pivotal role. A new treatment that can mitigate the worst effects of COVID-19, and ultimately a preventative vaccine, could, literally, save the world.

But as Stephen Ezell and Philip Stevens write in *IPWatchdog,* such life-saving technology is less likely to be forthcoming if, in their panic, governments sacrifice intellectual property (IP) rights for new COVID-19 therapeutics and vaccines.

---
*Source: Information Technology & Innovation Foundation (ITIF)*
*URL: https://itif.org/publications/2020/04/18/dont-let-life-sciences-innovation-become-another-coronavirus-casualty/*